Century Therapeutics Inc.

NASDAQ: IPSC · Real-Time Price · USD
0.56
0.01 (1.82%)
At close: Aug 15, 2025, 3:59 PM
0.58
3.17%
After-hours: Aug 15, 2025, 05:56 PM EDT

Century Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
58.44M 47.32M 84.27M 56.45M
Short-Term Investments
130.85M 125.41M 231.23M 166.43M
Long-Term Investments
30.82M 89.1M 51.85M 135.91M
Other Long-Term Assets
3.3M 2.52M 3.24M 3.49M
Receivables
1.52M 665K 780K 250K
Inventory
n/a n/a n/a -250K
Other Current Assets
506K 1.01M 462K 3.42M
Total Current Assets
194.05M 176.99M 319.72M 228.15M
Property-Plant & Equipment
90.85M 92.08M 111.73M 69.82M
Goodwill & Intangibles
34.2M n/a n/a n/a
Total Long-Term Assets
159.16M 183.7M 166.82M 209.22M
Total Assets
353.22M 360.69M 486.54M 437.38M
Account Payables
3.08M 2.74M 5.45M 7.6M
Deferred Revenue
109.16M 4.37M 7.15M 5.32M
Short-Term Debt
n/a n/a 6.5M 1.04M
Other Current Liabilities
4.97M 2.72M 3.17M 980K
Total Current Liabilities
129.78M 17.85M 29.82M 15.65M
Long-Term Debt
n/a n/a 3.74M 8.9M
Other Long-Term Liabilities
8.74M 56K 718K 2.02M
Total Long-Term Liabilities
62.07M 158.09M 153.99M 25.48M
Total Liabilities
191.85M 175.94M 183.81M 41.14M
Total Debt
53.83M 48.17M 49.41M 23.46M
Common Stock
9K 6K 6K 5K
Retained Earnings
-782.34M -655.77M -519.1M -388.17M
Comprehensive Income
324K 108K -2.46M -650K
Shareholders Equity
161.36M 184.75M 302.74M 396.24M
Total Investments
161.67M 214.51M 283.09M 302.35M